A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This is a study in healthy subjects. There are two parts to the study. In the first part of
the study each subject will receive a single 10mg dose of each of the four formulations of
E550. Based on the results from Part 1, an optimal formulation will be selected for further
evaluation in Part 2.